Article révisé par les pairs
Titre:
  • Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.
Auteur:Kim, Chungyeul; Tang, Gong; Pogue-Geile, Katherine L; Costantino, Joseph P; Baehner, Frederick L; Baker, Joffre; Cronin, Maureen T; Watson, Drew; Shak, Steven; Bohn, Olga L; Fumagalli, Debora; Taniyama, Yusuke; Lee, Ahwon; Reilly, Megan L; Vogel, Victor G; McCaskill-Stevens, Worta; Ford, Leslie G; Geyer, Charles E; Wickerham, D Lawrence; Wolmark, Norman; Paik, Soonmyung
Informations sur la publication:Journal of clinical oncology, 29, 31, page (4160-4167)
Statut de publication:Publié, 2011-11
Sujet CREF:Sciences biomédicales
Cancérologie
MeSH keywords:Adult
Aged
Antineoplastic Agents, Hormonal -- therapeutic use
Breast Neoplasms -- chemistry -- drug therapy -- prevention & control
Down-Regulation
Estrogen Receptor alpha -- genetics -- metabolism
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Linear Models
Middle Aged
Neoplasms, Hormone-Dependent -- chemistry -- drug therapy -- prevention & control
Protein Array Analysis
RNA, Messenger -- metabolism
Retrospective Studies
Tamoxifen -- therapeutic use
Treatment Outcome
Tumor Markers, Biological -- genetics -- metabolism
Note générale:Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2010.32.9615
info:pii/JCO.2010.32.9615
info:pmid/21947828
PMC3208536

Documents en relation

DI-fusion